Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

Richard Oakley of the Alzheimer's Society spoke to Newsweek about why now is an "exciting time" in the battle against the ...

Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first medication ...

Scientists do not fully understand what causes the chronic neurodegenerative disease Alzheimer's, but they are examining a ...

Dementia affects more than 6 million Americans and U.S. cases are expected to double by 2060, so it’s worth knowing when to ...

Donald Trump announced a drug deal with Pfizer in the Oval Office several weeks ago. During his remarks to the press, Trump ...

“New-onset anxiety, depression, or irritability in your 60s can be an early and often overlooked sign of Alzheimer’s disease, ...

More than 70% of people over 70 years old will one day develop cardiovascular disease, highlighting the need for effective ...